Lecture 6 - Autoimmune Disorders Flashcards

1
Q

what are the targets for autoimmune disorders?

A

protein antigens or nucleic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how do self-reactive T or B cells form?

A

gene rearrangement created lymphocytes that are specific for self-antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how are self-reactive lymphocytes removed?

A

destroyed or down regulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where does central self tolerance occur?

A

thymus or bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the mechanism of central self tolerance?

A

clonal deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the mechanisms of peripheral central tolerance?

A

anergy, cell death and immune deviation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

where do T cells form and develop?

A

originate in bone marrow but develop in thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what cells undergo positive selection?

A

only cells that bind to self MHC with low affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what cells undergo negative selection?

A

cells that bind with high affinity to self MHC and peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what cells undergo apoptosis in central tolerance?

A

cells that fail to interact with any MHC or peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how are T reg cells made?

A

some self-reactive T cells that encounter self antigens in the thymus develop into T reg cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens to B cells that recognise self antigens?

A

they are deleted or become self tolerant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what us clonal deletion?

A

physical elimination of a cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is Clonal anergy?

A

lack of co-stimulation or low affinity antigen binding leads to cells not being activated through signalling blocks or inhibitory receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is regulation in peripheral tolerance?

A

regulation or suppression caused by inhibition of cellular activites by interaction with other cells such as T reg cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is immune privilege?

A

limited lymphatic drainage with low levels of MHC expression and expression of FasL to kill infiltrating T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what happens to B cells that are exposed to lots of soluble antigen?

A

down regulate surface IgM and become anergic, up regulate fasmolecules to cause apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how do B cells change their antigen specificity?

A

when binding to an antigen with low affinity they re-express their RAG-1 and RAG-2 genes which cause DNA recombination

19
Q

what is susceptibility phase?

A

before onset of disease, influences by genetic factors that effect tolerance induction, regulation and HLA associations

20
Q

what is the initiation phase?

A

hidden epitopes revealed or new ones created

21
Q

how are new epitopes created?

A

post translational modification, proteolytic cleavage of intracellular antigens

22
Q

what is the propagation phase?

A

corresponds with the onset of clinical disease, tissue damage provides antigen to further drive immune responses

23
Q

what is the regulation/resolution phase?

A

immunoregulatory pathways that result in natural inhibition or resolution of the disease, quite rare

24
Q

what are the factors associated with organ specific autoimmunity?

A

affects one organ yet can be directed against multiple antigens on that organ

25
Q

how is non-organ specific autoimmunity caused?

A

as associated with self-molecules that are widely distributed, often associated with connective tissue

26
Q

what are the methods used to detect antibodies?

A

IF, RIA, ELISA, Immunoprecipitation, multiplex, immunoblot

27
Q

what are the different antigens used in the lab?

A

cells, tissues or purified or recombinant antigens

28
Q

how are cells prepped for lab use?

A

extracted via chemical extraction such as lysis buffer or mechanical extraction such as freeze thaw

29
Q

how are tissues prepped for lab use?

A

frozen or embedded into parafin

30
Q

why is purification of antigens important?

A

maintains conformational epitopes, structure and postranslational modifications

31
Q

what are the types of antisera?

A

hybridoma, polyclonal or monoclonal

32
Q

what is a hybridoma?

A

single clone of B cells that are fused with myeloma cell to immortalises them

33
Q

what are the qualitative tests?

A

immunofluorescence, immunodiffusion, immunoprecipitation

34
Q

what are the quantitative tests?

A

ELISA, microarray

35
Q

how is rheumatoid factor determined?

A

nephelometry or turbidometry

36
Q

how does counter-immunoelectrophoresis work?

A

electrical current applied across a gel, antigen moves towards the anode and antibody moves towards cathode, forming line or precipitation

37
Q

what can direct immunofluorescence be used to investigate?

A

complement and Ig deposition in tissue

38
Q

what is ELISA most commonly used to detect?

A

autoAB

39
Q

what are the types of multiplex technologies?

A

planar arrays and suspension arrays

40
Q

what are antinuclear antibodies?

A

antibodies directed against nuclear components of cells

41
Q

what are antinuclear antibodies used to investigate?

A

connective tissue diseases

42
Q

what are the membrane anionic phospholipids?

A

cardiolipin and phosphatidylserine

43
Q

what are the targets for antiphospholipid antibodies?

A

phospholipid binding proteins or phospholipid protein complexes

44
Q

what are the clinical presentations of antiphospholipid antibodies?

A

autoimmune disease characterised by vascular thrombosis and pregnancy morbidity